Internal Reference Number: FOI_9292
Date Request Received: 17/03/2026 00:00:00
Date Request Replied To: 02/04/2026 00:00:00
This response was sent via: By Email
Request Summary: Lupus
Request Category: Researcher
| Question Number 1: Does your Trust treat patients for Lupus Nephritis? (ICD-10 Code: M32.14 SNOMED Code: 68815009) If the Trust doesn’t treat patients for Lupus Nephritis, to which Trust does the Trust refer patients on for treatment? | |
| Answer To Question 1: No patients treated for this diagnosis in the period 01/01/2018 - 31/12/2025. | |
| Question Number 2: Please see attached. | |
| Answer To Question 2: 0 patients to report | |
| Question Number 3: How many patients have received treatment in the latest four-month period (November 2025 to February 2026 if available) for Lupus Nephritis with the following treatments regimens? (ICD-10 Code: M32.14 SNOMED Code: 68815009) • Standard Therapy (Steroids + Mycophenolate Mofetil (MMF)) • Cyclophosphamide (EuroLupus regimen) • Belimumab (Benlysta) • Voclosporin (Lupkynis) • Obinutuzumab (Gazyvaro) • Ritixumab (MabThera or biosimilars) • Rituximab (any other brand) • Any other targeted therapy (please state if possible) | |
| Answer To Question 3: 0 patients to report | |
| Please see Attachments: | |
| To return to the list of all the FOI requests please click here | |
Our staff at ÐÇ¿ÕÎÞÏÞ have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
